2020
The cytoreductive prostatectomy in metastatic prostate cancer: what the individual trials are hoping to answer
Ranasinghe W, Chapin B, Kim I, Sooriakumaran P, Lawrentschuk N. The cytoreductive prostatectomy in metastatic prostate cancer: what the individual trials are hoping to answer. BJU International 2020, 125: 792-800. PMID: 32176456, DOI: 10.1111/bju.15055.Peer-Reviewed Original ResearchConceptsHormone-sensitive metastatic prostate cancerMetastatic prostate cancerCytoreductive prostatectomyAndrogen deprivation therapyProstate cancerOverall survivalRadical prostatectomyLimited bone metastasesCancer-specific outcomesLocal treatment optionsProgression-free survivalDiagnosis of metastasisPrimary outcome measureNovel treatment algorithmOligometastatic settingAdjuvant treatmentMetastatic settingSecondary endpointsCastration resistanceMetastatic diseaseStandard therapyBone metastasesDefinitive treatmentOngoing trialsTreatment algorithm
2010
Early assessment of patient satisfaction and health-related quality of life following robot-assisted radical prostatectomy
Choi E, Jeong J, Kang D, Johnson K, Jang T, Kim I. Early assessment of patient satisfaction and health-related quality of life following robot-assisted radical prostatectomy. Journal Of Robotic Surgery 2010, 4: 221-227. PMID: 27627949, DOI: 10.1007/s11701-010-0212-0.Peer-Reviewed Original ResearchRobot-assisted radical prostatectomyHealth-related qualityGroup 1Patient satisfactionStorage symptomsSexual functionRadical prostatectomyGroup 2Group 3Expanded Prostate Cancer Index CompositeProstate Cancer Index CompositeCancer-specific HRQOLPeri-operative characteristicsLocalized prostate cancerHRQOL subscale scoresLower scoresHormonal botherBowel functionConsecutive patientsDefinitive treatmentProstate cancerDissatisfied patientsPatientsHRQoLStatistical difference